Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Eric Gordon

Sports Medicine Little Rock, AR Medical Doctor

NPI 1295776037 CMS profile 1226145

800 Fair Park Blvd, Little Rock, AR 72204

Open in the dashboard

General payments

$13,288

83 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Eric Gordon of Little Rock, AR is reported in the CMS Open Payments database as having received $13,288 across 83 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 62nd percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,168 10
2024 General $3,158 11
2022 General $337 1
2021 General $1,476 9
2020 General $3,049 17
2019 General $4,098 35

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Eric Gordon
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to Eric Gordon were reported at $1,168. Among 2,404 Sports Medicine profiles paid that year, the median was $664 and the middle half received between $172 and $3,055.

Show as a table
Year Eric Gordon Sports Medicine median Middle half National median
2019 $4,098 $1,176 $199–$4,249 $163
2020 $3,049 $708 $96–$2,890 $114
2021 $1,476 $1,213 $152–$3,994 $132
2022 $337 $1,230 $159–$3,998 $149
2023 $0 $584 $146–$2,836 $160
2024 $3,158 $628 $163–$3,168 $164
2025 $1,168 $664 $172–$3,055 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. MicroPort Orthopedics Inc $3,370 11 payments
  2. Arthrex, Inc. $2,938 28 payments
  3. United Orthopedics LLC $2,282 2 payments
  4. Zimmer Biomet Holdings, Inc. $1,690 17 payments
  5. Midsouth Orthopedics $1,222 2 payments
  6. Medical Device Business Services, Inc. $914 6 payments
  7. Smith+Nephew, Inc. $336 5 payments
  8. Flexion Therapeutics, Inc. $210 3 payments
  9. Abbott Laboratories $172 1 payment
  10. DePuy Synthes Sales Inc. $48 1 payment
  11. Other $106 7 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $6,282 29 payments
  2. Education $4,894 5 payments
  3. Food and Beverage $2,111 49 payments
Products named General payments · program years 2019–2025
  1. MPO Medial Pivot Knee $3,370 11 payments
  2. Oxford $982 8 payments
  3. ATTUNE $914 6 payments
  4. ACTIS $914 6 payments
  5. ROSA $442 6 payments
  6. Zilretta $210 3 payments
  7. ETERNA $172 1 payment
  8. Regeneten $144 1 payment
  9. Avitus Bone Harvester $125 1 payment
  10. Persona Revision $117 1 payment
  11. Other $394 14 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 12 drugs

Part D claims

668

Median for Orthopedic Surgery: 203

Drug cost

$4,844

Median for Orthopedic Surgery: $1,433

Branded share of claims

21.1%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Diclofenac Sodium Generic 93 $1,022
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 90 $716
Tranexamic Acid Generic 39 $669
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 51 $611
Ibuprofen Generic 55 $432
Meloxicam Generic 150 $400
Mupirocin Generic 41 $315
Gabapentin Generic 21 $253
Ondansetron Hcl Generic 42 $230
Cephalexin Generic 37 $115

The 10 drugs with the highest cost, of 12 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 85 billing codes

Paid by Medicare

$127,110

Of which drugs: $12,920

Medicare patients

339

Average age 73

Services billed

2,756

205 women, 134 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 71%
Ischemic heart disease 34%
Depression 27%
Diabetes 26%
Chronic kidney disease 19%
Atrial fibrillation 17%
COPD 16%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg J7325 Office 12 864 $6,105
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 74 423 $2,223

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

83 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in Arkansas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record